1. Home
  2. CBL vs ABCL Comparison

CBL vs ABCL Comparison

Compare CBL & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • ABCL
  • Stock Information
  • Founded
  • CBL 1978
  • ABCL 2012
  • Country
  • CBL United States
  • ABCL Canada
  • Employees
  • CBL N/A
  • ABCL N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBL Real Estate
  • ABCL Health Care
  • Exchange
  • CBL Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • CBL 828.5M
  • ABCL 772.9M
  • IPO Year
  • CBL 1993
  • ABCL 2020
  • Fundamental
  • Price
  • CBL $25.11
  • ABCL $2.14
  • Analyst Decision
  • CBL
  • ABCL Strong Buy
  • Analyst Count
  • CBL 0
  • ABCL 4
  • Target Price
  • CBL N/A
  • ABCL $8.33
  • AVG Volume (30 Days)
  • CBL 127.8K
  • ABCL 4.1M
  • Earning Date
  • CBL 05-05-2025
  • ABCL 05-08-2025
  • Dividend Yield
  • CBL 11.12%
  • ABCL N/A
  • EPS Growth
  • CBL 2069.88
  • ABCL N/A
  • EPS
  • CBL 2.16
  • ABCL N/A
  • Revenue
  • CBL $528,212,000.00
  • ABCL $23,114,000.00
  • Revenue This Year
  • CBL N/A
  • ABCL N/A
  • Revenue Next Year
  • CBL N/A
  • ABCL $36.62
  • P/E Ratio
  • CBL $11.66
  • ABCL N/A
  • Revenue Growth
  • CBL 0.03
  • ABCL N/A
  • 52 Week Low
  • CBL $21.10
  • ABCL $1.89
  • 52 Week High
  • CBL $33.54
  • ABCL $4.07
  • Technical
  • Relative Strength Index (RSI)
  • CBL 52.44
  • ABCL 50.63
  • Support Level
  • CBL $24.03
  • ABCL $1.98
  • Resistance Level
  • CBL $25.52
  • ABCL $2.08
  • Average True Range (ATR)
  • CBL 0.56
  • ABCL 0.10
  • MACD
  • CBL 0.02
  • ABCL 0.02
  • Stochastic Oscillator
  • CBL 50.12
  • ABCL 74.07

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: